CDC - An MMWR report finds that patients with COVID-19 had almost 16 times the risk for myocarditis, or inflammation of part of the heart muscle, compared with patients who did not
![JPM | Free Full-Text | Myocarditis and Pericarditis following COVID-19 Vaccination: Inequalities in Age and Vaccine Types JPM | Free Full-Text | Myocarditis and Pericarditis following COVID-19 Vaccination: Inequalities in Age and Vaccine Types](https://pub.mdpi-res.com/jpm/jpm-11-01106/article_deploy/html/images/jpm-11-01106-g001.png?1635420779)
JPM | Free Full-Text | Myocarditis and Pericarditis following COVID-19 Vaccination: Inequalities in Age and Vaccine Types
![Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination — PCORnet, United States, January 2021–January 2022 | MMWR Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination — PCORnet, United States, January 2021–January 2022 | MMWR](https://www.cdc.gov/mmwr/volumes/71/wr/social-media/mm7114e1_Post-infectionMyocarditis_IMAGE_1April22_1200x675_1.jpg?_=68123)
Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination — PCORnet, United States, January 2021–January 2022 | MMWR
![Occurrence and Features of Childhood Myocarditis: A Nationwide Study in Finland | Journal of the American Heart Association Occurrence and Features of Childhood Myocarditis: A Nationwide Study in Finland | Journal of the American Heart Association](https://www.ahajournals.org/cms/asset/14fa630a-fce6-4060-a612-42aa505c7049/jah32761-fig-0001.gif)
Occurrence and Features of Childhood Myocarditis: A Nationwide Study in Finland | Journal of the American Heart Association
![Weighing myocarditis cases, ACIP failed to balance the harms vs benefits of 2nd doses | by Wesley Pegden | Medium Weighing myocarditis cases, ACIP failed to balance the harms vs benefits of 2nd doses | by Wesley Pegden | Medium](https://miro.medium.com/v2/resize:fit:1400/1*5a49B6J1AY1zDrqs8kPcTw.png)
Weighing myocarditis cases, ACIP failed to balance the harms vs benefits of 2nd doses | by Wesley Pegden | Medium
![Systematic analysis of drug-associated myocarditis reported in the World Health Organization pharmacovigilance database | Nature Communications Systematic analysis of drug-associated myocarditis reported in the World Health Organization pharmacovigilance database | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-021-27631-8/MediaObjects/41467_2021_27631_Fig1_HTML.png)
Systematic analysis of drug-associated myocarditis reported in the World Health Organization pharmacovigilance database | Nature Communications
![The Global Burden of Myocarditis: Part 1: A Systematic Literature Review for the Global Burden of Diseases, Injuries, and Risk Factors 2010 Study - ScienceDirect The Global Burden of Myocarditis: Part 1: A Systematic Literature Review for the Global Burden of Diseases, Injuries, and Risk Factors 2010 Study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2211816014000192-gr4.jpg)
The Global Burden of Myocarditis: Part 1: A Systematic Literature Review for the Global Burden of Diseases, Injuries, and Risk Factors 2010 Study - ScienceDirect
Vaccines and Related Biological Products Advisory Committee June 14, 2022 Meeting Presentation - Update on myocarditis following
![NEJM on Twitter: "Among 2.5 million patients who received the BNT162b2 mRNA vaccine in a large Israeli health care system, the incidence of myocarditis at 42 days was 2.13 cases per 100,000 NEJM on Twitter: "Among 2.5 million patients who received the BNT162b2 mRNA vaccine in a large Israeli health care system, the incidence of myocarditis at 42 days was 2.13 cases per 100,000](https://pbs.twimg.com/media/FBDOwg1VIAQY3JF.jpg)
NEJM on Twitter: "Among 2.5 million patients who received the BNT162b2 mRNA vaccine in a large Israeli health care system, the incidence of myocarditis at 42 days was 2.13 cases per 100,000
![JCM | Free Full-Text | Occurrence, Trends, Management and Outcomes of Patients Hospitalized with Clinically Suspected Myocarditis—Ten-Year Perspectives from the MYO-PL Nationwide Database JCM | Free Full-Text | Occurrence, Trends, Management and Outcomes of Patients Hospitalized with Clinically Suspected Myocarditis—Ten-Year Perspectives from the MYO-PL Nationwide Database](https://www.mdpi.com/jcm/jcm-10-04672/article_deploy/html/images/jcm-10-04672-g001.png)
JCM | Free Full-Text | Occurrence, Trends, Management and Outcomes of Patients Hospitalized with Clinically Suspected Myocarditis—Ten-Year Perspectives from the MYO-PL Nationwide Database
![Is Myocarditis an Independent Risk Factor for Post-Transplant Mortality in Pediatric Heart Transplant Recipients? | Circulation: Heart Failure Is Myocarditis an Independent Risk Factor for Post-Transplant Mortality in Pediatric Heart Transplant Recipients? | Circulation: Heart Failure](https://www.ahajournals.org/cms/asset/740b1796-0c6e-46a5-b23a-6c0ff4b31208/e002328fig02.jpeg)
Is Myocarditis an Independent Risk Factor for Post-Transplant Mortality in Pediatric Heart Transplant Recipients? | Circulation: Heart Failure
![Association Between COVID-19 and Myocarditis Using Hospital-Based Administrative Data — United States, March 2020–January 2021 | MMWR Association Between COVID-19 and Myocarditis Using Hospital-Based Administrative Data — United States, March 2020–January 2021 | MMWR](https://www.cdc.gov/mmwr/volumes/70/wr/figures/mm7035e5-F1.gif?_=14295)
Association Between COVID-19 and Myocarditis Using Hospital-Based Administrative Data — United States, March 2020–January 2021 | MMWR
![Trends in myocarditis incidence, complications and mortality in Sweden from 2000 to 2014 | Scientific Reports Trends in myocarditis incidence, complications and mortality in Sweden from 2000 to 2014 | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-022-05951-z/MediaObjects/41598_2022_5951_Fig2_HTML.png)